molnupiravir 200 MG Oral Capsule [Lagevrio]
RxNorm concept 2603740, branded drug (sbd). Prescribable name: Lagevrio 200 MG Oral Capsule (EUA).
- RxCUI
- 2603740
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2603740 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Related concepts
- molnupiravir 200 MG (SCDC, consists of)
- molnupiravir 200 MG [Lagevrio] (SBDC, consists of)
- Oral Capsule (DF, has dose form)
- Lagevrio (BN, has ingredient)
- molnupiravir 200 MG Oral Capsule (SCD, tradename of)
Linked data
NDCs
- 00006505506
- 00006505507
- 00006505509
- 50090684100
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2603740 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2603740 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2603740. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.